Clinical Trial Update: Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET) [NA]

View source ↗

Summary

A clinical trial led by Institut Curie to characterize the immune infiltrate and molecular features of thymic epithelial tumors (thymomas and thymic carcinomas)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymic Epithelial Tumor
• Thymoma

Snippet

Sponsor: Institut Curie | Conditions: Cancer | NA | Status: RECRUITING